Sector valuations Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Berne S.E.
2026-08-14
|
5-day change | 1st Jan Change | ||
| 225.03 CHF | -2.88% |
|
+5.49% | - |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 33.04x | 4.4x | 1.27x | 5.91x | 17.56x | 24.7x | 0.97% | 48.42B | ||
| -21.14x | 22.11x | -0.34x | 288.75x | -21.43x | -20.64x | -.--% | 43.66B | ||
| 45.52x | 7.71x | 0.23x | 5.25x | 28.69x | 33.16x | -.--% | 39.51B | ||
| 30.48x | 5.57x | -31.93x | 3.03x | 13.08x | 19.76x | -.--% | 38.95B | ||
| 30.58x | 2.49x | 0.64x | 8.82x | 22.17x | 26.41x | 0.38% | 32.61B | ||
| 32.9x | 23.6x | 2.18x | 5.38x | 24.45x | 25.58x | -.--% | 16.15B | ||
| 23.48x | 2.63x | 0.68x | 2.05x | 8.89x | 13.76x | 1.15% | 14.16B | ||
| 74.93x | 4.44x | -0.33x | 3.96x | 15.35x | 18.86x | -.--% | 13.37B | ||
| 27.64x | 1.31x | 0.27x | 1.83x | 11.26x | 12.82x | -.--% | 12.59B | ||
| 46.54x | 5.04x | 3.76x | 5.27x | 22.16x | 35x | 0.49% | 12.12B | ||
| 60.84x | 5.2x | 0.38x | 9.27x | 26.36x | 28.8x | 0.44% | 11.28B | ||
| -28.96x | 8.52x | 1.09x | 103.44x | -29.45x | -51.24x | -.--% | 10.25B | ||
| -26.41x | 9.12x | -8.65x | 11054.5x | -21.83x | -21.5x | -.--% | 10.24B | ||
| -28.86x | 9.26x | -2.75x | - | -25.48x | -25.54x | -.--% | 10.15B | ||
| 33.49x | - | -0.1x | 17.53x | 32.54x | 31.6x | -.--% | 10.04B | ||
| -36.52x | 19.11x | -31.21x | 6.22x | 152.24x | -2025.71x | -.--% | 9.4B | ||
| -30.48x | 8.81x | -6.96x | 79.66x | -20.25x | -19.71x | -.--% | 9.76B | ||
| -16.02x | 662.65x | -0.32x | 10.22x | -16.51x | -15.95x | -.--% | 9.51B | ||
| Average | 13.95x | 47.17x | -4.01x | 683.01x | 13.32x | -106.10x | 0.19% | 19.56B | |
| Weighted average by Cap. | 19.33x | 27.00x | -4.39x | 377.91x | 12.30x | -42.79x | 0.25% |
Select your edition
All financial news and data tailored to specific country editions
















